Blue Owl Tech (OTF) Q1 2026 Earnings Transcript

Blue Owl Technology Finance reported Q1 adjusted net investment income of $0.29 per share and NAV of $16.49, down from $17.33, with the decline driven mainly by market-based mark-to-market pressure rather than credit deterioration. The company declared a $0.35 regular dividend plus a $0.05 special dividend, completed $50 million of buybacks, and ended with over $2.3 billion of liquidity and net leverage at 0.85x, just below its target range. Management remains cautious on software exposure and said it may take longer for earnings to cover the base dividend, but emphasized low non-accruals, strong repayment activity, and improving sentiment around AI and software credits.

Analysis

The key read-through is that OTF is transitioning from a “prove the credit” story to a “prove the re-rating” story. The near-term earnings pressure is mostly mechanical: lower floating income, spread compression on recent vintages, and slower balance-sheet ramp, while the mark-to-market hit is actually a feature of its underwriting model in a de-risking market. That matters because if software sentiment keeps improving, the fund gets a double tailwind: NAV recovery from wider marks and faster deployment into still-widened new-money spreads.

The second-order winner is likely GEHC, not just as an acquirer in one repayment, but as a beneficiary of more rational software M&A and refinancing conditions. If public software multiples stabilize, sponsors should accelerate take-private and recap activity, which should support origination volume for OTF and also compress spreads for weaker lenders that are forced to de-risk. Conversely, competitors with less differentiated sourcing or weaker sponsor access may see assets drift away just as OTF has the balance-sheet capacity to lean in.

The main risk is timing: management is explicitly signaling that dividend coverage may lag longer than previously expected, so the stock can remain a yield trap for several quarters even if credit stays pristine. The market is currently paying for the dividend but not for optionality, which means the catalyst path likely needs 1) continued public software recovery, 2) another month or two of stable credit marks, and 3) visible leverage ramp toward target. If those three don’t line up by late summer, the stock could re-rate back on coverage concerns despite strong underlying loans.

The contrarian setup is that the market may be over-discounting AI disruption risk in software while underpricing the value of OTF’s structured exposure and sponsor-backed senior book. Management’s own language implies it is willing to shrink lower-conviction software exposure at the margin and redeploy into adjacent verticals with less correlation, which is a subtle positive for long-run ROE. The stock looks like a call option on a narrowing of software fear combined with a slow but durable earnings ramp; the downside is mostly time decay, not obvious credit blowup.

Key Decisions for Investors

• Long OTF common for a 3-6 month horizon only if you can tolerate carry risk; risk/reward improves on any pullback toward discount-to-NAV extremes because the setup is a NAV-recovery plus dividend-support story, not a near-term EPS story.
• Pair trade: long OTF / short a weaker BDC with less software differentiation and tighter dividend coverage, to isolate relative recovery in higher-quality tech credit while reducing market beta.
• Use OTF Jan-2027 calls instead of common to express the re-rating view; the option structure better matches the expected 6-12 month catalyst window and limits damage if dividend-coverage concerns persist.
• Watch GEHC as a secondary beneficiary; if software M&A accelerates, GEHC-like acquirers should benefit from better deal flow and lower integration-risk pricing. Favor GEHC on pullbacks as a lower-volatility way to express improving tech-credit sentiment.
• If software indices stall for 4-6 weeks and OTF’s shares stop outperforming NAV recovery, fade the long and rotate to capital-return beneficiaries with cleaner near-term coverage rather than waiting for the dividend thesis to validate.